Add BrightSurf on Google Email

Effect of cessation of nucleos(t)ide treatment in HBeAg-negative chronic hepatitis B on HBsAg loss: A randomized controlled multicenter trial

Home | Story
2 institutional releases

Published in Journal of Hepatology · View the paper (DOI)

A study published in Journal of Hepatology found that some patients with chronic hepatitis B can achieve sustained immune control by discontinuing antiviral therapy after four years. This suggests a potential cure for the disease, which affects an estimated 350 million people worldwide.

Coverage from 2 institutions

  • How to achieve a functional cure for chronic hepatitis B
    • Article 1 Universität Leipzig · Mar 30, 2023 · first to report
    • Article 2 Elsevier · Mar 30, 2023